Presentatör: Hans Jeppsson, CFO Presentation, datum och tid: 26 november kl 16:15 CET
C21 shows promise against COVID-19 where other drugs have failed
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Report on the ATTRACT study
Top line data on the ATTRACT study
Patient insights to shape development of a dCBT for IPF patients